Literature DB >> 20172119

Chronic atrial fibrillation is associated with reduced survival after aortic and double valve replacement.

Richard Schulenberg1, Polychronis Antonitsis, Andrie Stroebel, Stephen Westaby.   

Abstract

BACKGROUND: Although chronic atrial fibrillation (AF) is thought to negatively affect survival after aortic valve replacement (AVR), evidence is limited and intraoperative methods to restore sinus rhythm are not widely adopted. This study investigated long-term outcome in valve prosthesis patients with or without AF.
METHODS: Between 1994 and 2006, 420 patients with the same mechanical prosthesis were prospectively entered into a database; 90 had chronic AF preoperatively. Medical therapy was used to attempt to restore sinus rhythm postoperatively, but none had intraoperative ablation. All were anticoagulated with warfarin and monitored serially in National Health Service (United Kingdom) clinics. Survival and adverse events were determined by detailed review.
RESULTS: Mean follow-up was 79.5 months (range, 18 months to 13.5 years); 12 were lost to follow-up. Procedures included 225 AVRs with or without coronary bypass (AVR with CABG), 151 mitral valve replacements (MVR) with CABG, and 32 double-valve replacements (DVR). Preoperative AF patients remained in the same rhythm 6 months postoperatively. Prosthesis-related events were infrequent. For chronic AF patients, mortality at 10 years was greater after AVR (64.3% vs 19.2% p < 0.001), AVR with CABG (83.3% vs 21.3% p < 0.001), and DVR (80.0% vs 17.6% p < 0.001). Survival after isolated MVR or MVR with CABG (p > 0.05) was similar. Most MVR with CABG patients in sinus rhythm had acute ischemic mitral regurgitation. Greater age (p = 0.001) and preoperative AF (p = 0.02) were risk factors for death.
CONCLUSIONS: Chronic AF negatively affects survival after AVR with or without CABG and DVR with a mechanical prosthesis. Prospective randomized evaluation of AF ablation is suggested for these patients. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20172119     DOI: 10.1016/j.athoracsur.2009.12.023

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Atrail Fibrillation after Carfiac Surgery: Benign or Deserving of Prophylaxis.

Authors:  Stephen Westaby
Journal:  J Atr Fibrillation       Date:  2010-12-15

2.  Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial.

Authors:  Angelo B Biviano; Tamim Nazif; Jose Dizon; Hasan Garan; Jessica Fleitman; Dua Hassan; Samir Kapadia; Vasilis Babaliaros; Ke Xu; Rupa Parvataneni; Josep Rodes-Cabau; Wilson Y Szeto; William F Fearon; Danny Dvir; Todd Dewey; Mathew Williams; Michael J Mack; John G Webb; D Craig Miller; Craig R Smith; Martin B Leon; Susheel Kodali
Journal:  Circ Cardiovasc Interv       Date:  2016-01       Impact factor: 6.546

3.  Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery.

Authors:  Akshat Saxena; Diem Dinh; Jim Dimitriou; Christopher Reid; Julian Smith; Gilbert Shardey; Andrew Newcomb
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-03

4.  Performance of the Cox-maze IV procedure is associated with improved long-term survival in patients with atrial fibrillation undergoing cardiac surgery.

Authors:  Farah N Musharbash; Matthew R Schill; Laurie A Sinn; Richard B Schuessler; Hersh S Maniar; Marc R Moon; Spencer J Melby; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2017-09-27       Impact factor: 5.209

Review 5.  Management strategies in cardiac surgery for postoperative atrial fibrillation: contemporary prophylaxis and futuristic anticoagulant possibilities.

Authors:  George Tokmaji; R Scott McClure; Tsuyoshi Kaneko; Sary F Aranki
Journal:  Cardiol Res Pract       Date:  2013-12-05       Impact factor: 1.866

6.  Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study.

Authors:  Maunu Nissinen; Joonas Lehto; Fausto Biancari; Tuomo Nieminen; Markus Malmberg; Fredrik Yannopoulos; Samuli Salmi; Juhani K E Airaksinen; Tuomas Kiviniemi; Juha E K Hartikainen
Journal:  Clin Cardiol       Date:  2020-02-05       Impact factor: 2.882

Review 7.  Advances in catheter ablation: atrial fibrillation ablation in patients with mitral mechanical prosthetic valve.

Authors:  Pasquale Santangeli; Luigi Di Biase; Rong Bai; Rodney Horton; J David Burkhardt; Javier Sanchez; Justin Price; Andrea Natale
Journal:  Curr Cardiol Rev       Date:  2012-11

8.  Atrial fibrillation in aortic stenosis--echocardiographic assessment and prognostic importance.

Authors:  Charlotte Burup Kristensen; Jan Skov Jensen; Peter Sogaard; Helle Gervig Carstensen; Rasmus Mogelvang
Journal:  Cardiovasc Ultrasound       Date:  2012-09-25       Impact factor: 2.062

9.  Bipolar radiofrequency ablation is useful for treating atrial fibrillation combined with heart valve diseases.

Authors:  Lin Chen; Yingbin Xiao; Ruiyan Ma; Baicheng Chen; Jia Hao; Chuan Qin; Wei Cheng; Renguo Wen
Journal:  BMC Surg       Date:  2014-05-22       Impact factor: 2.102

10.  Ascending aortic aneurysm repair and surgical ablation for atrial fibrillation.

Authors:  Berhane Worku; Iosif Gulkarov; Charles A Mack; Leonard N Girardi; Arash Salemi
Journal:  J Cardiothorac Surg       Date:  2015-11-26       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.